abs161.txt	neoplastic	cellularity	contributes	to	the	analytic	sensitivity	of	most	presenttechnologies	for	mutation	detection		such	that	they	underperform	when	stroma	andinflammatory	cells	dilute	a	cancer	specimen's	variant	fraction	thus	tumorpurity	assessment	by	light	microscopy	is	used	determine	sample	adequacy	beforesequencing	and	interpret	significance	negative	results	mutantallele	afterwards	however	pathologist	estimates	tumor	purity	areimprecise	have	limited	reproducibility	with	advent	massively	parallelsequencing	large	amounts	molecular	data	can	be	analyzed	computationalpurity	algorithms	we	retrospectively	compared	3	computationalalgorithms	using	hematoxylin	eosin	lightmicroscopy	which	was	best	clinical	evaluation	molecularprofiling	were	from	881	patients	trialcohort	lccc1108	(uncseq)	whose	tumors	had	targeted	concordance	among	poor	specimens	hadhigh	rates	algorithm	failure	partially	due	variable	computational	did	not	add	value	beyond	pathologist'sestimate	improve	present	methods	wepropose	semiquantitative	clinically	applicable	strategy	based	on	mutant	allelefraction	copy	number	changes	within	given	specimen	whencombined	morphologic	estimate	guide	interpretation	ofnext-generation	sequencing	in	this	an	open-accessarticle	distributed	under	terms	creative	commons	attribution-noncommercial-no	derivatives	license	4	0	(ccby-nc-nd)	where	it	permissible	todownload	share	work	provided	properly	cited	cannot	bechanged	any	way	or	commercially	without	permission	journal	http	//creativecommons	org/licenses/by-nc-nd/4	0/
